Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alexander K. Ebralidze, Ph.D.

Concepts (226)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Alexander Ebralidze's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Alexander Ebralidze has written about over time.
Transcription, Genetic, 14 publications between 1987 and 2021, average publication date September 2001. Myotonic Dystrophy, 2 publications between 2001 and 2003, average publication date July 2002. Muscle Cells, 1 publications between 2003 and 2003, average publication date December 2003. RNA, 3 publications between 1989 and 2023, average publication date June 2005. RNA, Antisense, 1 publications between 2008 and 2008, average publication date July 2008. Regulatory Sequences, Nucleic Acid, 2 publications between 2008 and 2011, average publication date February 2010. Trans-Activators, 8 publications between 2003 and 2021, average publication date February 2011. Granulocytes, 4 publications between 2006 and 2016, average publication date February 2011. Proto-Oncogene Proteins, 6 publications between 2006 and 2021, average publication date March 2011. Promoter Regions, Genetic, 10 publications between 1990 and 2021, average publication date February 2012. Myeloid Cells, 7 publications between 2007 and 2021, average publication date October 2013. Leukemia, Myeloid, Acute, 8 publications between 2006 and 2021, average publication date June 2014. CCAAT-Enhancer-Binding Protein-alpha, 3 publications between 2009 and 2017, average publication date July 2014. CCAAT-Enhancer-Binding Proteins, 4 publications between 2012 and 2021, average publication date July 2015. Core Binding Factor Alpha 2 Subunit, 4 publications between 2007 and 2021, average publication date September 2015. DNA Methylation, 6 publications between 2009 and 2023, average publication date February 2016. Gene Expression Regulation, Leukemic, 5 publications between 2012 and 2021, average publication date December 2016. Hemopexin, 1 publications between 2020 and 2020, average publication date September 2020. Core Binding Factor beta Subunit, 1 publications between 2021 and 2021, average publication date October 2021.

To see the data from this visualization as text, click here.
Ebralidze's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (226)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.